WO2003072571A1 - Sel d'un derive de pyridyle ethanolamine et son utilisation en tant qu'agoniste du recepteur beta-adrenergique - Google Patents

Sel d'un derive de pyridyle ethanolamine et son utilisation en tant qu'agoniste du recepteur beta-adrenergique Download PDF

Info

Publication number
WO2003072571A1
WO2003072571A1 PCT/IB2003/000575 IB0300575W WO03072571A1 WO 2003072571 A1 WO2003072571 A1 WO 2003072571A1 IB 0300575 W IB0300575 W IB 0300575W WO 03072571 A1 WO03072571 A1 WO 03072571A1
Authority
WO
WIPO (PCT)
Prior art keywords
salt
monohydrate
pyridin
phenoxy
oxazol
Prior art date
Application number
PCT/IB2003/000575
Other languages
English (en)
Inventor
Joseph Francis Krzyzaniak
Jennifer Anne Lafontaine
Original Assignee
Pfizer Products Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Products Inc. filed Critical Pfizer Products Inc.
Priority to AU2003248355A priority Critical patent/AU2003248355A1/en
Publication of WO2003072571A1 publication Critical patent/WO2003072571A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Abstract

La présente invention a trait au sel de tosylate de (R)-2-(2-(-(4-oxazol-4-yl-phénoxy)-éthylamino)-1-pyridin-3-yl-éthanol, le monohydrate d'un tel sel, des procédés utiles dans la préparation d'un tel sel et d'un tel monohydrate, des compositions pharmaceutiques comprenant un tel sel, ou un tel monohydrate, des méthodes de traitement de maladies provoquées par le récepteur β-3 adrénergique, de conditions, et de troubles chez un mammifère utilisant un tel sel, un tel monohydrate, ou de telles compositions pharmaceutiques, et des méthodes permettant l'accroissement de la teneur de viande maigre chez des animaux comestibles utilisant un tel sel, un tel monohydrate, ou de telles compositions pharmaceutiques.
PCT/IB2003/000575 2002-02-27 2003-02-17 Sel d'un derive de pyridyle ethanolamine et son utilisation en tant qu'agoniste du recepteur beta-adrenergique WO2003072571A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2003248355A AU2003248355A1 (en) 2002-02-27 2003-02-17 Salt of a pyridyl ethanolamine derivative and its use as a beta-3-adrenergic receptor agonist

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US36024802P 2002-02-27 2002-02-27
US60/360,248 2002-02-27

Publications (1)

Publication Number Publication Date
WO2003072571A1 true WO2003072571A1 (fr) 2003-09-04

Family

ID=27766205

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2003/000575 WO2003072571A1 (fr) 2002-02-27 2003-02-17 Sel d'un derive de pyridyle ethanolamine et son utilisation en tant qu'agoniste du recepteur beta-adrenergique

Country Status (8)

Country Link
AR (1) AR038603A1 (fr)
AU (1) AU2003248355A1 (fr)
GT (1) GT200300044A (fr)
PA (1) PA8567601A1 (fr)
PE (1) PE20030900A1 (fr)
TW (1) TW200305414A (fr)
UY (1) UY27678A1 (fr)
WO (1) WO2003072571A1 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065877A1 (fr) * 1998-06-13 1999-12-23 Glaxo Group Limited Derives de biaryle therapeutiques
WO2002032897A1 (fr) * 2000-10-20 2002-04-25 Pfizer Products Inc. Ethanolamines alpha-aryle et utilisation de ces dernieres en tant qu'agonistes du recepteur adrenergique beta-3

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999065877A1 (fr) * 1998-06-13 1999-12-23 Glaxo Group Limited Derives de biaryle therapeutiques
WO2002032897A1 (fr) * 2000-10-20 2002-04-25 Pfizer Products Inc. Ethanolamines alpha-aryle et utilisation de ces dernieres en tant qu'agonistes du recepteur adrenergique beta-3

Also Published As

Publication number Publication date
UY27678A1 (es) 2003-10-31
GT200300044A (es) 2003-09-22
AU2003248355A1 (en) 2003-09-09
PE20030900A1 (es) 2003-10-25
AR038603A1 (es) 2005-01-19
TW200305414A (en) 2003-11-01
PA8567601A1 (es) 2003-12-10

Similar Documents

Publication Publication Date Title
US5843972A (en) Heterocyclic β-adrenergic agonists
US5977124A (en) β-adrenergic agonists
EP1087943B1 (fr) Derives de biaryle therapeutiques
CA2211866A1 (fr) Agonistes des recepteurs beta-adrenergiques
MXPA97008621A (en) Agonistasó-adrenergicos, compositions that contain and use of mis
AU2001292161A1 (en) Alpha-aryl ethanolamines and their use as beta-3 adrenergic receptor agonists
CA1296002C (fr) Thiazoles et oxazoles substitues, medicaments a base de ces composes et procedes de preparation
JPH11504648A (ja) β−アドレナリン作動性アゴニスト
US6689800B2 (en) β3-adrenergic receptor agonist crystal forms, processes for the production thereof, and uses thereof
CH667454A5 (fr) Derives d'indoles.
JPH1192372A (ja) るいそう状態を低減するためのβ−アドレナリン作働性アゴニスト
CN1030753A (zh) 制备新的取代n-(3-羟基-4-哌啶基)苯甲酰胺的方法
US6689888B2 (en) Processes and intermediates useful in preparing β3-adrenergic receptor agonists
US6514991B2 (en) Phenyl-oxo-tetrahydroquinolin-3-yl beta-3 adrenergic receptor agonists
WO2003072571A1 (fr) Sel d'un derive de pyridyle ethanolamine et son utilisation en tant qu'agoniste du recepteur beta-adrenergique
US5026702A (en) Morpholines and morpholine-N-oxides and pharmaceutical compositions containing these compounds
CN1090629C (zh) 新的杂环化合物
JP2000506498A (ja) アリールエタノールアミン誘導体および非定型β―アドレノセプターのアゴニストとしてのそれらの用途
KR950006714B1 (ko) 치환된 티아졸 및 옥사졸
AU4747599A (en) Intermediates for the preparation of beta-adrenergic agonists
CH667870A5 (fr) Derives des phenethanolamines, procedes de preparation et compositions pharmaceutiques les contenant.

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ OM PH PL PT RO RU SC SD SE SG SK SL TJ TM TN TR TT TZ UA UG US UZ VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP